{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-018507","form_type":"8-K","ticker":"SYRA","cik":"0001922335","company_name":"Syra Health Corp","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.217779+00:00","generated_at":"2026-06-02T07:14:53.910230+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Syra Health Q1 revenue up 47% to $1.7M, net loss widens to $1.4M; FY2024 guidance $9-11M","bullets":["Revenue $1.7M vs $1.2M Q1 2023; Population Health grew 212% YoY; Healthcare Workforce up 28%.","Net loss $(1.4M) vs $(0.8M); Adjusted EBITDA $(1.4M) vs $(0.8M).","Gross margin 10.2% (12.4% Q1 2023) due to mix shift to Healthcare Workforce.","Cash $3.2M, no long-term debt; FY2024 revenue guidance $9-11M (64-100% growth).","Awarded contracts: $660K HEDIS, $480K Indiana, $450K Shelby County, $250K DC; active in 19 states."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-018507","json":"https://secwatch.observer/filing/0001493152-24-018507.json","markdown":"https://secwatch.observer/filing/0001493152-24-018507.md","text":"https://secwatch.observer/filing/0001493152-24-018507.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224018507/0001493152-24-018507-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224018507/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T07:14:53.910230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d255fc630ac7829ed350db69c7cbdaaf478360b9","claim":"Syra Health Corp reported first quarter ended March 31, 2024 results: revenue $1.7 million, net income $(1.4 million). Guidance reaffirmed.","evidence_excerpt":"innovative services and technology solutions, announced today its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights ● Revenue of $1.7 million in 1Q24 compared to $1.2 million in 1Q23. ● Business units excluding Healthcare Workforce grew 333% and comprised 19% of total revenues in 1Q24, versus only 7% in 1Q23. ●","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224018507/0001493152-24-018507-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$1.7 million"},{"label":"Net income","value":"$(1.4 million)"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}